To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
EQT Life Sciences surpasses hard-cap to reach €260m for inaugural dementia fund
The life sciences unit increased its original €175m hard-cap to allow for more investment into the portfolio companies it seeks to back.
